AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization for TEPKINLY® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R2) for the ...

Every year, across the length and breadth of the African continent, a familiar and colorful ritual plays out .

After dismantling the main US body for delivering foreign assistance last year, the Trump administration is again offering ...

Around the 2026 FIFA World Cup, Hyundai and Boston Dynamics have taught footwork to the Atlas humanoid, while the Spot robot ...